Publications database

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

This country overview, summarising the drug situation in Kyrgyzstan, was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology...

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European...

The result of the EMCDDA’s cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by...

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

This summary of the national drug situation in Kazakhstan was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology...

This summary of the national drug situation in Kazakhstan was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology...

This summary of the national drug situation in Uzbekistan was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology...